Cizova Profile
Key Indicators
- Authorised Capital ₹ 1.51 Cr
- Paid Up Capital ₹ 1.51 Cr
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.15 Cr
- Satisfied Charges ₹ 1.00 Cr
- Revenue Growth 3.46%
- Profit Growth 38.67%
- Ebitda 178.60%
- Net Worth 8.20%
- Total Assets 9.66%
About Cizova
Cizova Private Limited (CPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 February 2017 (Seven years and 11 months 23 days old ). Its registered office is in Chamrajpet, Bengaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.51 Cr and a paid-up capital of Rs 1.51 Cr.
The company currently has active open charges totaling ₹3.15 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Avinash Polepalli and Polepalli Nagabhushanam serve as directors at the Company.
Company Details
-
Location
Chamrajpet, Bengaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909KA2017PTC100316
-
Company No.
100316
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Feb 2017
-
Date of AGM
02 Nov 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Cizova?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Polepalli
|
Director | 08-Feb-2017 | Current |
|
Polepalli Nagabhushanam
|
Director | 08-Feb-2017 | Current |
Financial Performance of Cizova.
Cizova Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.46% increase. The company also saw a substantial improvement in profitability, with a 38.67% increase in profit. The company's net worth moved up by a moderate rise of 8.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cizova?
In 2023, Cizova had a promoter holding of 66.18% and a public holding of 33.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.15 Cr
₹1.00 Cr
Charges Breakdown by Lending Institutions
- Others : 3.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2018 | Others | ₹6.50 M | Open |
| 05 Jun 2017 | Others | ₹2.50 Cr | Open |
| 08 Aug 2018 | Others | ₹1.00 Cr | Satisfied |
How Many Employees Work at Cizova?
Unlock and access historical data on people associated with Cizova, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cizova, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cizova's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.